EXELIXIS, INC. (EXEL) revenue & profit
EXELIXIS, INC. (EXEL): revenue $2.3B, net income $782.6M in 2025; latest quarter +10.6% year over year. From SEC filings.
$2.3BRevenue 2025
TickerEXEL (Nasdaq)
IndustryHealthcare · Biological Products, (No Diagnostic Substances)
Revenue 2025$2.3B
Net income 2025$782.6M
Net margin33.7%
Annual revenue growth+7%
Latest quarter (2026 Q2) · Revenue$628.7M
vs. same quarter last year+10.6%
Latest quarter · Net income$212.1M
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $1.6B | $182.3M | |
| 2023 | $1.8B | $207.8M | |
| 2024 | $2.2B | $521.3M | |
| 2025 | $2.3B | $782.6M |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.